Literature DB >> 110907

Molecular characterization of a small Haemophilus influenzae plasmid specifying beta-lactamase and its relationship to R factors from Neisseria gonorrhoeae.

R Laufs, P M Kaulfers, G Jahn, U Teschner.   

Abstract

The ampicillin-resistant Haemophilus influenzae strain Ve445 which caused purulent meningitis and septicaemia in a newborn child in Germany contained a 4.4 megadalton (Mdal) plasmid (pVe445) and produced a TEM type beta-lactamase. The transformation to ampicillin resistance of a sensitive Escherichia coli strain with isolated pVe445 DNA proved that the structural gene for the beta-lactamase resided on this plasmid genome. Molecular DNA-DNA hybridization studies and electron microscope DNA heteroduplex analysis indicated that pVe445 probably contained 38 to 41% of the ampicillin translocation DNA segment (TnA) found on R factors of enteric origin. The TnA fragment present in pVe445 most likely does not contain both of the inverted repeat sequences of TnA. DNA-DNA polynucleotide sequence studies indicated that the 4.4 Mdal plasmid pVe445 was unrelated to the 30 to 38 Mdal H. influenzae R plasmids but was closely related to the 4.1 Mdal ampicillin resistance specifying H. influenzae plasmid RSF0885 isolated in the U.S.A. The H. influenzae plasmid pVe445 shared 91% of its base sequences with the beta-lactamase specifying Neisseria gonorrhoeae plasmid pMR0360 (4.4 Mdal) and had 85% of its base sequences in common with the beta-lactamase specifying N. gonorrhoeae plasmid pMR0200 (3.2 Mdal). All of the four 3.2 to 4.4 Mdal beta-lactamase specifying R plasmids of H. influenzae and N. gonorrhoeae investigated probably have a common evolutionary origin.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 110907     DOI: 10.1099/00221287-111-1-223

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  17 in total

1.  A novel type of resistance plasmid in Haemophilus influenzae.

Authors:  J C Piffaretti; T Camponovo; B Borer-Bigliardi; A Arini
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

Review 2.  Haemophilus influenzae: antibiotic susceptibility.

Authors:  C A Needham
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

3.  Molecular nature of a plasmid specifying beta-lactamase production in Haemophilus ducreyi.

Authors:  J Brunton; P Bennett; J Grinsted
Journal:  J Bacteriol       Date:  1981-12       Impact factor: 3.490

4.  Sequence-specific DNA uptake in transformation of Neisseria gonorrhoeae.

Authors:  J F Graves; G D Biswas; P F Sparling
Journal:  J Bacteriol       Date:  1982-12       Impact factor: 3.490

5.  TEM-type beta-lactamase production in Haemophilus ducreyi.

Authors:  I W MacLean; G H Bowden; W L Albritton
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191

6.  Plasmid-mediated tetracycline resistance in Haemophilus ducreyi.

Authors:  W L Albritton; I W Maclean; L A Slaney; A R Ronald; H G Deneer
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

7.  Haemophilus influenzae: comparison of respiratory tract isolates with genitourinary tract isolates.

Authors:  W L Albritton; J L Brunton; M Meier; M N Bowman; L A Slaney
Journal:  J Clin Microbiol       Date:  1982-11       Impact factor: 5.948

8.  Penicillinase-producing Neisseria gonorrhoeae: a molecular comparison of 5.3-kb and 7.4-kb beta-lactamase plasmids.

Authors:  N Dickgiesser; P M Bennett; M H Richmond
Journal:  J Bacteriol       Date:  1982-09       Impact factor: 3.490

9.  Characterization of ampicillin resistance plasmids from Haemophilus ducreyi.

Authors:  P A Totten; H H Handsfield; D Peters; K K Holmes; S Falkow
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

10.  Molecular epidemiology of beta-lactamase-specifying plasmids of Haemophilus ducreyi.

Authors:  J Brunton; M Meier; N Ehrman; I Maclean; L Slaney; W L Albritton
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.